GlassScriptPhysician profile
Timothy C Wagner
NPI 1992143739
$185,009.22
in general payments reported to CMS, 2019-2025
18 companies · $15K in 2025
The $15K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,699 · 2020: $7,801 · 2021: $31K · 2022: $85K · 2023: $33K · 2024: $4,509 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Education: $9,540 · Travel and Lodging: $3,560 · Food and Beverage: $3,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,825.00 |
| Education | $9,540.00 |
| Travel and Lodging | $3,559.52 |
| Food and Beverage | $3,533.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $138,135.82 | 2019-2025 | Rosa, Persona, G7 |
| Medical Device Business Services, INC. | $23,169.68 | 2019-2025 | Reclaim, Attune, Velys |
| Stryker Corporation | $8,649.93 | 2019-2025 | Mako, Triathlon, Orthomap |
| Next Science LLC | $7,539.19 | 2021-2022 | |
| Smith+Nephew, INC. | $3,909.79 | 2019-2023 | |
| Depuy Synthes Sales INC. | $1,945.95 | 2019-2025 | Velys |
| Arthrex, INC. | $1,000.00 | 2021 | |
| Orthalign INC | $211.38 | 2025 | Orthalign Plus |
| Ethicon US, LLC | $130.44 | 2020-2022 | |
| Pacira Therapeutics, INC. | $113.88 | 2019 | |
| Encore Medical, LP | $49.59 | 2019 | |
| Conmed Corporation | $25.96 | 2020 | |
| Davol INC. | $24.72 | 2025 | Arista |
| Solventum Corporation | $23.91 | 2025 | Prevena |
| Abbvie INC. | $23.37 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $23.31 | 2022 | |
| Glaxosmithkline, LLC. | $18.15 | 2023 | Trelegy Ellipta |
| Idorsia Pharmaceuticals US INC | $14.15 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.